Hemostatic and thrombotic issues in cardiac surgery

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 1, 2015, Pages 84-90

  Ranucci, Marco ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

bleeding; cardiac surgery; cardiopulmonary bypass; point of care tests; transfusions

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTITHROMBIN; APIXABAN; APROTININ; CLOPIDOGREL; DABIGATRAN; FRESH FROZEN PLASMA; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; RIVAROXABAN; THROMBIN; TICAGRELOR; TRANEXAMIC ACID; HEMOSTATIC AGENT;

ARTICLE; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING PARAMETERS; CARDIOPULMONARY BYPASS; HEART SURGERY; HEMOSTASIS; HUMAN; HYPERFIBRINOLYSIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SEIZURE; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; THROMBOEMBOLISM; THROMBOPLASTIN TIME; ADVERSE EFFECTS; PROCEDURES; THROMBOSIS;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HEMOSTATICS; HUMANS; THROMBOSIS;

EID: 84928388328     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1398383     Document Type: Article

References (68)

1. Wells A. W., Llewelyn C. A., Casbard A., et al. The EASTR Study: indications for transfusion and estimates of transfusion recipient numbers in hospitals supplied by the National Blood Service. Transfus Med: 2009; 19 6 315 328
2. US Department of Health and Human Services. The 2007 Nationwide Blood Collection and Utilization Survey Report. Washington, DC Department of Health and Human Services: 2007
3. Bakaeen F. G., Chu D., Kelly R. F., Holman W. L., Jessen M. E., Ward H. B. Perioperative outcomes after on- and off-pump coronary artery bypass grafting. Tex Heart Inst J: 2014; 41 2 144 151
4. Filsoufi F., Rahmanian P. B., Castillo J. G., Bronster D., Adams D. H. Incidence, topography, predictors and long-term survival after stroke in patients undergoing coronary artery bypass grafting. Ann Thorac Surg: 2008; 85 3 862 870
5. Sastry P., Hardman G., Page A., et al. Mesenteric ischaemia following cardiac surgery: the influence of intraoperative perfusion parameters. Interact Cardiovasc Thorac Surg: 2014; 19 3 419 424
6. Ranucci M., Bozzetti G., Ditta A., Cotza M., Carboni G., Ballotta A. Surgical reexploration after cardiac operations: why a worse outcome? Ann Thorac Surg: 2008; 86 5 1557 1562
7. Ranucci M., Baryshnikova E., Castelvecchio S., Pelissero G.; Surgical and Clinical Outcome Research (SCORE) Group. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg: 2013; 96 2 478 485
8. Murphy G. J., Reeves B. C., Rogers C. A., Rizvi S. I., Culliford L., Angelini G. D. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation: 2007; 116 22 2544 2552
9. Edmunds L. H. Jr, Colman R. W. Thrombin during cardiopulmonary bypass. Ann Thorac Surg: 2006; 82 6 2315 2322
10. Boisclair M. D., Lane D. A., Philippou H., et al. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood: 1993; 82 11 3350 3357
11. Chung J. H., Gikakis N., Rao A. K., Drake T. A., Colman R. W., Edmunds L. H. Jr. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation: 1996; 93 11 2014 2018
12. De Somer F., Van Belleghem Y., Caes F., et al. Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. J Thorac Cardiovasc Surg: 2002; 123 5 951 958
13. Albes J. M., Stöhr I. M., Kaluza M., et al. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg: 2003; 126 5 1504 1512
14. Wippermann J., Albes J. M., Hartrumpf M., et al. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg: 2005; 28 1 127 132
15. Ranucci M., Balduini A., Ditta A., Boncilli A., Brozzi S. A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg: 2009; 87 4 1311 1319
16. Ranucci M., Frigiola A., Menicanti L., Ditta A., Boncilli A., Brozzi S. Postoperative antithrombin levels and outcome in cardiac operations. Crit Care Med: 2005; 33 2 355 360
17. Boyle E. M. Jr, Verrier E. D., Spiess B. D. Endothelial cell injury in cardiovascular surgery: the procoagulant response. Ann Thorac Surg: 1996; 62 5 1549 1557
18. Yang L., Vuylsteke A., Gerrard C., Besser M., Baglin T. Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain. J Thromb Haemost: 2013; 11 8 1519 1526
19. Despotis G. J., Santoro S. A., Spitznagel E., et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg: 1994; 107 1 271 279
20. Khan N. U., Wayne C. K., Barker J., Strang T. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol: 2010; 27 7 624 627
21. Galeone A., Rotunno C., Guida P., et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth: 2013; 27 5 853 858
22. Ternström L., Radulovic V., Karlsson M., et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res: 2010; 126 2 e128 e133
23. Bosch Y. P., Al Dieri R., ten Cate H., et al. Measurement of thrombin generation intra-operatively and its association with bleeding tendency after cardiac surgery. Thromb Res: 2014; 133 3 488 494
24. Puetz J. Fresh frozen plasma: the most commonly prescribed hemostatic agent. J Thromb Haemost: 2013; 11 10 1794 1799
25. Tanaka K. A., Mazzeffi M. A., Grube M., Ogawa S., Chen E. P. Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery. Transfusion: 2013; 53 4 920 921
26. Arnékian V., Camous J., Fattal S., Rézaiguia-Delclaux S., Nottin R., Stéphan F. Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interact Cardiovasc Thorac Surg: 2012; 15 3 382 389
27. Gill R., Herbertson M., Vuylsteke A., et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation: 2009; 120 1 21 27
28. Levi M., Peters M., Büller H. R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med: 2005; 33 4 883 890
29. Sorensen B., Spahn D. R., Innerhofer P., Spannagl M., Rossaint R. Clinical review: Prothrombin complex concentrates-evaluation of safety and thrombogenicity. Crit Care: 2011; 15 1 201
30. Kindo M., Hoang Minh T., Gerelli S., et al. Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. Thromb Res: 2014; 134 2 360 368
31. Pillai R. C., Fraser J. F., Ziegenfuss M., Bhaskar B. Influence of circulating levels of fibrinogen and perioperative coagulation parameters on predicting postoperative blood loss in cardiac surgery: a prospective observational study. J Card Surg: 2014; 29 2 189 195
32. Faraoni D., Willems A., Savan V., Demanet H., De Ville A., Van der Linden P. Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. Eur J Anaesthesiol: 2014; 31 6 317 326
33. Shainoff J. R., Estafanous F. G., Yared J. P., DiBello P. M., Kottke-Marchant K., Loop F. D. Low factor XIIIA levels are associated with increased blood loss after coronary artery bypass grafting. J Thorac Cardiovasc Surg: 1994; 108 3 437 445
34. Blome M., Isgro F., Kiessling A. H., et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost: 2005; 93 6 1101 1107
35. Kalina U., Stöhr H. A., Bickhard H., et al. Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis: 2008; 19 8 777 783
36. O'Shaughnessy D. F., Atterbury C., Bolton Maggs P., et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol: 2004; 126 1 11 28
37. Rossaint R., Bouillon B., Cerny V., et al. Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: an updated European guideline. Crit Care: 2010; 14 2 R52
38. Rahe-Meyer N. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery. Thromb Res: 2011; 128 01 S17 S19
39. Karlsson M., Ternström L., Hyllner M., Baghaei F., Nilsson S., Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion: 2008; 48 10 2152 2158
40. Theusinger O. M., Baulig W., Seifert B., Emmert M. Y., Spahn D. R., Asmis L. M. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma. Br J Anaesth: 2011; 106 4 505 511
41. Pantanowitz L., Kruskall M. S., Uhl L. Cryoprecipitate. Patterns of use. Am J Clin Pathol: 2003; 119 6 874 881
42. Ranucci M., Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth: 2012; 109 2 135 137
43. Kozek-Langenecker S. A., Afshari A., Albaladejo P., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol: 2013; 30 6 270 382
44. Karkouti K., von Heymann C., Jespersen C. M., et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg: 2013; 146 4 927 939
45. McCall M. M., Blackwell M. M., Smyre J. T., et al. Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trial. Ann Thorac Surg: 2004; 77 3 983 987, discussion 987
46. Oliver W. C. Jr, Beynen F. M., Nuttall G. A., et al. Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg: 2003; 75 5 1506 1512
47. Ranucci M., Carlucci C., Isgrò G., Baryshnikova E. A prospective pilot study of platelet function and its relationship with postoperative bleeding in pediatric cardiac surgery. Minerva Anestesiol: 2012; 78 5 556 563
48. Greilich P. E., Brouse C. F., Beckham J., Jessen M. E., Martin E. J., Carr M. E. Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res: 2002; 105 6 523 529
49. Ferraris V. A., Brown J. R., Despotis G. J., et al. Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion; International Consortium for Evidence Based Perfusion. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg: 2011; 91 3 944 982
50. Pickard A. S., Becker R. C., Schumock G. T., Frye C. B. Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy: 2008; 28 3 376 392
51. Berger J. S., Frye C. B., Harshaw Q., Edwards F. H., Steinhubl S. R., Becker R. C. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. J Am Coll Cardiol: 2008; 52 21 1693 1701
52. Ferraris V. A., Ferraris S. P., Saha S. P., et al. Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg: 2007; 83 (5, Suppl): S27 S86
53. Fitchett D., Eikelboom J., Fremes S., et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol: 2009; 25 12 683 689
54. Ferraris V. A., Saha S. P., Oestreich J. H., et al. Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg: 2012; 94 5 1761 1781
55. Di Dedda U., Ranucci M., Baryshnikova E., Castelvecchio S.; Surgical and Clinical Outcome Research Group. Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg: 2014; 45 1 165 170
56. Tantry U. S., Bonello L., Aradi D., et al. Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol: 2013; 62 24 2261 2273
57. Ranucci M., Baryshnikova E., Soro G., Ballotta A., De Benedetti D., Conti D.; Surgical and Clinical Outcome Research (SCORE) Group. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg: 2011; 91 1 123 129
58. Weber C. F., Görlinger K., Meininger D., et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology: 2012; 117 3 531 547
59. Steinlechner B., Zeidler P., Base E., et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg: 2011; 91 5 1420 1426
60. Teufelsbauer H., Proidl S., Havel M., Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost: 1992; 68 3 250 252
61. Royston D., Bidstrup B. P., Taylor K. M., Sapsford R. N. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet: 1987; 2 8571 1289 1291
62. Levi M., Cromheecke M. E., de Jonge E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet: 1999; 354 9194 1940 1947
63. Mangano D. T., Miao Y., Vuylsteke A., et al. Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA: 2007; 297 5 471 479
64. Fergusson D. A., Hébert P. C., Mazer C. D., et al. BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med: 2008; 358 22 2319 2331
65. Murkin J. M., Falter F., Granton J., Young B., Burt C., Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesth Analg: 2010; 110 2 350 353
66. Mangano D. T.; Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med: 2002; 347 17 1309 1317
67. Hill J., Treasure T. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery: summary of NICE guidance. BMJ: 2007; 334 7602 1053 1054
68. Ranucci M., Baryshnikova E., Crapelli G. B., Woodward M. K., Paez A., Pelissero G. Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg: 2013; 145 5 1393 1399